In this article
The short version
- Sermorelin is a lab-made copy of the signal that tells your pituitary to release its own growth hormone.
- In a placebo-controlled trial of older adults, nightly sermorelin raised IGF-1, the main growth hormone marker, about 40% in men.
- Studies used about 1 mg at bedtime. Your clinician sets your dose and adjusts it with your labs.
- The most common side effect is a sore, red, or swollen injection spot, in about 1 in 6 people.
- The FDA-approved version was discontinued in 2008, not for safety reasons. Today's sermorelin is compounded.
Your body makes the most growth hormone in your teens and twenties. After that, output drops decade after decade, and a lot of people feel it. That's why so many people end up searching for sermorelin.
Sermorelin doesn't add growth hormone from outside. It tells your own pituitary to release more, mostly while you sleep. In one placebo-controlled trial, nightly sermorelin raised IGF-1, the main growth hormone marker, by about 40% in men. Here's what it is, what the studies showed, how it's dosed, and the side effects to know.
What sermorelin is (and why it isn't HGH)
Sermorelin is a lab-made copy of the first 29 building blocks of GHRH, the messenger your brain uses to tell your pituitary gland to release growth hormone. It's the shortest piece of that messenger with its full activity.
Think of it as a text message to your pituitary, not a delivery of hormone. Your pituitary still decides how much growth hormone to release, in natural bursts, and your body's built-in brakes still work.
Growth hormone then tells your liver to make IGF-1, which carries out many of its effects. IGF-1 stays steady through the day, so it's the number clinicians check in a blood test.
Why people use sermorelin
Growth hormone release falls hard with age. In a study of 149 healthy men, growth hormone output and deep sleep both dropped sharply between early adulthood and midlife. Many people connect that drop with what they feel: less energy, a softer middle, and slower recovery from workouts.
So people turn to sermorelin hoping to:
- Feel more like themselves as the years add up.
- Bring growth hormone signals closer to younger levels, which is exactly what IGF-1 tests track.
- Work with their own body instead of injecting growth hormone itself.
- Have a clinician watch the numbers, with labs instead of guesswork.
Those are goals, not guarantees. Here's what the research actually found.
What the studies actually showed
The best adult data come from placebo-controlled trials at the University of Washington. Healthy older adults, average age about 68, injected about 1 mg of sermorelin once each evening for 5 to 6 months.
In a shorter National Institute on Aging study, 1 mg twice a day for two weeks raised growth hormone and IGF-1 in older men to levels seen in young men.
What the trials didn't show matters too:
- Body and strength results were small and mixed. The researchers called them "very preliminary."
- Sleep didn't improve. Months of nightly injections didn't make sleep better.
- Women taking estrogen saw much smaller IGF-1 gains, under 10%.
- The studies were small and short. No long-term trials exist.
How sermorelin is prescribed and dosed
- A small shot under the skin at bedtime. Your biggest natural growth hormone pulse comes with deep sleep, so sermorelin is taken at night. The original label said once daily at bedtime.
- The doses used in studies. Adult studies used about 1 mg a night (about 14 mcg per kilogram), 0.5 to 1 mg twice a day, or 2 mg a night. The children's label dose was 30 mcg per kilogram nightly.
- Your clinician sets your dose. There's no FDA-set adult dose, so your clinician chooses a starting dose and adjusts it based on how you feel and what your labs show.
- Labs guide the plan. An IGF-1 test before and during treatment shows whether your body is responding. Thyroid tests matter too, because an underactive thyroid can blunt the response.
- Rotate where you inject. The original label recommended moving the injection spot each time.
Sermorelin side effects
Here's what the original label reported from trials in 350 children:
- Injection-site reactions (pain, swelling, or redness) were the most common, in about 1 in 6 people. Only 3 of 350 stopped because of them.
- Headache, flushing, dizziness, trouble swallowing, hyperactivity, sleepiness, and hives each happened in fewer than 1 in 100.
- Thyroid changes. About 6.5% developed an underactive thyroid during treatment, which is why thyroid checks are part of care.
- Antibodies were common but didn't affect results, and no body-wide allergic reactions were reported.
Medicines in the same family can raise blood sugar, so your clinician may check it too. Sermorelin isn't right for everyone. Talk with your clinician first if you're pregnant or breastfeeding, have had cancer, or have a thyroid problem. It's also banned in competitive sports.
Sermorelin's FDA history, in plain English
- 1990: FDA approved sermorelin, sold as Geref, as a test of growth hormone release.
- 1997: FDA approved Geref to treat children with growth hormone deficiency.
- 2008: The manufacturer discontinued Geref, and FDA withdrew the approvals in 2009.
- 2013: FDA formally found that Geref was not withdrawn for reasons of safety or effectiveness.
No FDA-approved sermorelin is sold today. The sermorelin clinicians prescribe now is compounded by licensed pharmacies, which means it isn't FDA-approved.
Nx Prime: sermorelin with a clinician in your corner
Nx Prime is Nirvanix's compounded sermorelin injection. A Nirvanix clinician reviews your health history, decides whether sermorelin fits your goals, and sets your dose. If it's prescribed, a licensed pharmacy prepares it and ships it to you, and your plan can change based on how you feel and what your labs show. The consultation is included, and there's no waiting room.
The bottom line
Sermorelin asks your own pituitary to release more growth hormone. In trials, nightly doses raised IGF-1 by 30% to 40%, with small, mixed results elsewhere and no sleep benefit. It's a nightly shot with mostly mild side effects, and a clinician should set your dose and watch your labs.
Curious whether it fits you? Take the two-minute quiz or see Nx Prime.
Common questions
What does sermorelin do?
Sermorelin signals your pituitary gland to release more of your own growth hormone, which raises IGF-1, the blood marker of growth hormone activity. In studies of older adults, nightly sermorelin raised IGF-1 by about 30% to 40%, bringing growth hormone signals closer to younger levels.
What is the usual sermorelin dosage?
There's no FDA-set adult dose. Adult studies mostly used about 1 mg injected under the skin at bedtime, and others used 0.5 to 2 mg. Your clinician sets your dose based on your health and labs, and adjusts it over time.
How long does sermorelin take to work?
In a two-week study, 1 mg twice a day raised IGF-1 in older men to levels typical of young men. Body changes in the main trial were measured after 5 to 6 months. How you feel varies, so your clinician tracks your labs and symptoms along the way.
Is sermorelin FDA-approved?
Not today. FDA approved sermorelin, sold as Geref, in 1990 and 1997, and the manufacturer discontinued it in 2008. FDA later found it wasn't withdrawn for reasons of safety or effectiveness. The sermorelin prescribed now is compounded, so it isn't FDA-approved.
Is sermorelin the same as HGH?
No. HGH is growth hormone itself. Sermorelin is a signal that asks your pituitary to release its own growth hormone, so your body's natural brakes still apply. The two have never been compared head to head in adults.



